The Government of Mauritius has set up the National Drug Observatory whose main objective is to monitor and assess the dangerous drugs situation in the country and to devise appropriate strategies to deal effectively with drug use.
IDPC offers an overview and analysis of the UNGASS, covering the adoption of the UNGASS outcome document, the plenary, roundtables and side events, as well as civil society engagement in and outside the UN building.
After almost 15 years since the fall of the Taliban, the policy discussion on counternarcotics remains uncertain of which way to proceed. In large part, this is because policy discussion is shaped by a superficial or misguided understanding of opium poppy and its role in rural livelihoods.
How can the outcomes of international drug control policy be measured? Currently, the UN drug control system lacks appropriate metrics to do so. However, the adoption of the Sustainable Development Goals offers a chance to find new – and potentially better – answers to this question.
Although the Action Plan facilitates the availability of evidence-based treatment options, calls for the implementation of harm reduction programs, and the collation of epidemiological data, key issues remain to be addressed.
The Council on International Relations of Latin America and the Caribbean (RIAL) analyses the lessons of the UNGASS for Latin America and advances strategies which would catalyse innovation in drug policy in the region.
The EMCDDA publishes a report providing an update on infectious diseases related to injecting drug use in Europe, it covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area.
The EMCDDA met to discuss how the Council conclusions on the implementation of minimum quality standards in drug demand reduction in the EU can relate to projects at national, European and international level.